LRLaura Rienzi

Laura Rienzi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Laura Rienzi has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Misleading messages from the web: professional medical counseling and public datasets vs. online health information in in vitro fertilization

    by Alberto Vaiarelli, Danilo Cimadomo, Christine Wyns, Diane De Neubourg, Georgina M. Chambers, Anja Pinborg, Jim P. Toner, Maurizio Guido, Laura Rienzi

  • Open Access

    NanoCT-confocal mapping of mouse ovaries reveals lifespan-persistent symmetric organizational rules of primary-to-preovulatory follicles

    by Giulia Fiorentino, Andrea Fantinato, Annapaola Parrilli, Tommaso Marzi, Cesare Alippi, Riccardo Bellazzi, Laura Rienzi, Filippo Maria Ubaldi, Alberto Vaiarelli, Valeria Merico, et al.

    SUMMARY: Mammalian ovaries are organized into follicles integrated with the surrounding tissue, collectively shaping an architecture continuously remodeled through cycles of growth and elimination. Combining nano-Computed Tomography with 3D digital modeling, we deciphered spatial rules governing follicle organization in the mouse ovary across lifespan. We find that primary to preovulatory follicles adopt a quantitatively symmetric arrangement along the anterior-posterior and dorsal-ventral axes, established during prepuberty before secondary follicle vascularization and preserved through adulthood and aging, regardless of follicle health or atresia. A novel nanoCT-confocal pipeline revealed that follicles enclosing oocytes with transcriptionally-active or transcriptionally-inactive chromatin states follow divergent fates of growth, atresia, or developmental competence, yet retaining a symmetric distribution. Mathematical modeling of follicle growth and elimination from prepuberty to adulthood identified transition rates between follicle stages that support gonadal symmetry. These findings suggest an evolutionarily optimized developmental program ensuring follicle recruitment and high ovulatory output, a hallmark of polytocous species.

  • Embryos not showing pronuclei by single static observation arise from atypical pronuclear dynamics or rare unfertilized oocytes with abortive cleavage behaviour

    by Giovanni Coticchio, Marilena Taggi, Francesca Asturi, Alfredo Stati, Maria Bordignon, Federica Innocenti, Gaia Saturno, Alberto Vaiarelli, Laura Rienzi, Danilo Cimadomo

    STUDY QUESTION: Is the non-pronuclear (0PN) fertilization pattern, as assessed by single static observation during the 16- to 18-h post-insemination (hpi) interval, compatible with embryo developmental competence? SUMMARY ANSWER: A few zygotes show pronuclei (PN) solely outside the static fertilization assessment time interval and can develop to blastocyst stage, while rare cases of cleavage without pronuclear formation always result in early developmental arrest or degeneration. WHAT IS KNOWN ALREADY: Recently, the use of atypically pronucleated zygotes—showing no, one, or three PN (0PN, 1PN, and 3PN), or other less frequent patterns—has been increasingly proposed as a measure to maximize the number of embryos available for treatment and the cumulative clinical outcome per cycle. The use of such zygotes poses important clinical and ethical concerns; it also raises scientific questions, such as the hypothesis that the 0PN pattern can be compatible with pre- and post-implantation development in the absence of actual formation of PN. Allowing detailed observation of embryo morphokinetics, time-lapse technology (TLT) can be decisive in resolving such questions. STUDY DESIGN, SIZE, DURATION: Retrospective observational study (2013–2020) including 6035 oocytes inseminated by ICSI and cultured in a time-lapse imaging incubator system. Zygotes (N = 4479), classified by PN-type, were divided into sub-groups based on timings of PN appearance (tPNa: 16hpi) and PN fading (tPNf: 20hpi). Their development was monitored until blastocyst stage. The remaining 1556 injected oocytes were either degenerated (N = 801) or did not show PN (true-0PN; N = 755). Among the latter, 186 showed ≥1 cleavage(s) and then degenerated. Their videos were analysed to assess events preceding developmental arrest. PARTICIPANTS/MATERIALS, SETTING, METHODS: Ovarian stimulation with GnRH-antagonist and hCG/agonist trigger was performed, with all patients undergoing ICSI and blastocyst culture. The study endpoints were the blastulation rates across different PN-appearance and -fading thresholds, as well as a thorough description of the events during cell division(s) in 0PN embryos that experienced early arrest. Regression analyses were conducted, adjusting for confounders such as maternal age, male factor, and PN-type, with associations confirmed using generalized estimating equations. MAIN RESULTS AND ROLE OF CHANCE: Zygotes showing two PN (2PN, N = 4479) monitored by TLT were distributed in sub-groups based on tPNf (20 hpi, N = 4115). In a few cases (N = 85), PN formation occurred after 16 hpi, up until 31 hpi. Single static observation during the 16- to 18-hpi conventional interval would have missed the zygotes undergoing very early PNf and at least part of those undergoing late PNa. Comparison between the above sub-groups showed that pronuclear fading occurring at 18–20 hpi was associated with the highest blastocyst formation rate (36.4%, 47.7%, 65.4%, and 53.3%, for the diverse tPNf, respectively; P < 0.001). Late tPNa (>16 hpi) was accompanied by reduced blastocyst formation rate (54.5% vs 29.4%; P < 0.001). tPNf occurring at 18–20 hpi was also associated with a higher blastocyst euploidy rate. Of 755 true-0PN oocytes, 186 (24.6%) underwent ≥1 cleavage(s). However, all of them arrested before compaction, often displaying irregular cleavage(s) (including direct, reverse, and chaotic), vacuolization, and/or extensive fragmentation. LIMITATIONS, REASONS FOR CAUTION: The study data are derived from a single, although large, dataset. Therefore, they require independent confirmation. In addition, assessment of fertilization morphokinetics can only be applied to ICSI insemination, leaving fertilization morphokinetics achieved by standard IVF unexplored. WIDER IMPLICATIONS OF THE FINDINGS: TLT confirms the limitations of single static observation, which fails to detect a significant proportion of zygotes, especially if executed relatively late. This has implications for fertilization assessment, prediction of blastulation, and utilization of atypically pronucleated zygotes. Moreover, TLT demystifies the belief that blastocyst development may occur in the absence of pronuclear formation. STUDY FUNDING/COMPETING INTEREST(S): None. TRIAL REGISTRATION NUMBER: None.


  • Optimizing IVF lab workflows through data-driven insights: associations between lab management, procedural timings, and workload with blastulation rates

    by Federica Innocenti, Greta Chiara Cermisoni, Marilena Taggi, Valentina Casciani, Daria Maria Soscia, Lisa Dovere, Marta Stoppa, Laura Albricci, Alberto Vaiarelli, Giovanni Coticchio, et al.

    STUDY QUESTION: Do IVF laboratory workflows influence the mean blastulation rate per cohort of inseminated metaphase II oocytes (m-BR)? SUMMARY ANSWER: Neither the total number of procedures nor the workload per operator affected m-BR; instead, each additional hour in the interval from ovulation trigger to oocyte denudation (range 36–44 h) was associated with a measurable decline, especially beyond the 40-h threshold. WHAT IS KNOWN ALREADY: Control of laboratory conditions and standardized protocols are essential for optimizing m-BR in IVF. While advancements in technology and culture systems have improved ART outcomes, the effect of laboratory managerial decisions and procedural timing on embryological outcomes remains unclear. Previous studies have suggested that factors, such as prolonged oocyte handling, suboptimal culture conditions, and organizational inefficiencies, may affect in vitro embryo development, but available data are still limited. STUDY DESIGN, SIZE, DURATION: This retrospective study analyzed 7986 ICSI cycles performed between 2015 and 2022 at a private IVF center. Data were automatically registered and then retrospectively extracted from an Electronic Witnessing System to evaluate workload distribution and procedural timings. The study aimed to assess whether variations in laboratory managerial decisions influence the m-BR. PARTICIPANTS/MATERIALS, SETTING, METHODS: The study included all patients undergoing ICSI with fresh own oocytes. Metrics under investigation included the number of daily procedures overall and per operator and procedural timings, such as the interval between ovulation trigger and oocyte denudation. Results were adjusted for confounders, including maternal age, male factor infertility, and culture conditions. Multivariate linear regression and generalized estimating equations were used to assess associations with m-BR, accounting for repeated measures in couples undergoing multiple retrievals. MAIN RESULTS AND THE ROLE OF CHANCE: The overall m-BR was 35.7 ± 28.1% with 79% of the cycles resulting in at least one blastocyst obtained. No significant association was found between daily workload and m-BR, indicating that the number of daily procedures did not impact laboratory performance. After adjusting for confounders (maternal age, sperm factor, incubation conditions, and culture medium type), only the timing between ovulation trigger and oocyte denudation emerged as critical. A consistent and significant decline in m-BR was observed with each additional hour of delay between 36- and 44-h post-trigger (unstandardized coefficient B: −1.6%, 95% CI: −2.1 to –1.1%). The time between oocyte retrieval and denudation (range: 2–6 h) showed a significant association with a lower chance to obtain at least one blastocyst in each ICSI cycle (adjusted OR: 0.91, 95% CI: 0.86–0.96, P < 0.001). LIMITATIONS, REASONS FOR CAUTION: This was a retrospective single-center study. While the findings are robust and relevant for high-volume IVF laboratories, they may not be directly generalizable to smaller clinics with different workflows or lower caseloads. Additionally, only ICSI cycles were included; further studies are needed to confirm the findings for conventional IVF in different settings and patient populations. WIDER IMPLICATIONS OF THE FINDINGS: These findings suggest that even large workloads can be managed without compromising IVF performance, provided that lab schedules and personnel are carefully coordinated to meet ideal timing requirements. In the future, artificial intelligence models may support these lab management activities by predicting workloads and helping maintain timely schedules. STUDY FUNDING/COMPETING INTEREST(S): No funding. The authors declare no conflict of interest related with the content of this study. TRIAL REGISTRATION NUMBER: N/A.


  • Artificial intelligence-based donor oocyte quality assessment moderately improves the prediction of blastocyst development: a first step towards higher personalization in the management of egg donation treatments

    by Danilo Cimadomo, Vicente Badajoz, Maria Hebles, Laura Mifsud, Cristina Urda, Teresa Sánchez, Aitana Sánchez, Cristina Ortega, Javier Ávila, Clara Mariné, et al.

    STUDY QUESTION: Can an artificial intelligence (AI)-based oocyte scoring system reliably predict the developmental competence of fresh donor oocytes? SUMMARY ANSWER: The AI-derived Magenta Score was significantly associated with fertilization, blastocyst formation, and helpful to estimate cumulative live birth rates, although a trend toward overestimation was observed in a subset of cycles. WHAT IS KNOWN ALREADY: Oocyte quality is a critical determinant of IVF success; however, standardized and objective methods for its assessment are lacking. Current allocation strategies in oocyte donation cycles often neglect recipient-related factors and risk overproduction of surplus embryos. AI-based evaluation may offer a more objective, reproducible alternative to traditional morphology-based assessment. STUDY DESIGN, SIZE, DURATION: Prospective, observational, multicenter, blinded cohort study including 1179 fresh metaphase II (MII) oocytes from 145 donors, allocated to 171 recipient couples across three IVF centers between June 2023 and October 2024. PARTICIPANTS/MATERIALS, SETTING, METHODS: Denuded MII oocytes were imaged at 200–400× magnification and assessed using an AI-based scoring system (Magenta Score, Future Fertility). The primary outcome was the association between Magenta Score and blastocyst development, adjusted for donor age, sperm motility, and culture medium. Secondary outcomes included associations with oocyte dysmorphisms, fertilization, blastocyst quality and timing, implantation, cumulative live birth rates, and accuracy of blastocyst yield predictions. MAIN RESULTS AND THE ROLE OF CHANCE: Oocytes with higher Magenta Scores had significantly higher rates of 2PN fertilization (odds ratio [OR] 1.08) and blastocyst formation (OR 1.19), independent of confounders. Magenta Score per se displayed an AUC of 0.6, reaching 0.62 if combined with donors’ age and 0.65 if also combined with male partners’ sperm motility 1%-increase and culture medium used, highlighting the multifactorial nature of embryo development. In 82% of cases, the actual blastocyst number fell within or above the predicted range extrapolated from the Magenta Scores of each cohort. A 10% increase in the predicted probability of achieving at least one live birth based on the Magenta Score was associated with a significantly higher true cumulative live birth rate (OR 1.55; AUC 0.691). LIMITATIONS, REASONS FOR CAUTION: The observational design precludes causal inference. Only fresh oocyte cycles were evaluated, limiting extrapolation to vitrified oocytes. Some donor oocytes were cryopreserved and excluded from analysis. Future randomized trials are needed to assess clinical utility when AI is actively used for allocation decisions. WIDER IMPLICATIONS OF THE FINDINGS: AI-based assessment of donor oocytes offers a promising tool to enhance the personalization and fairness of oocyte allocation in donation cycles. However, to maximize its clinical value, AI predictions should be integrated with additional donor-, recipient-, and cycle-specific variables. Further refinements and prospective validations are necessary to improve prediction accuracy and avoid overestimation, ultimately optimizing cumulative live birth rates while minimizing surplus embryo production. STUDY FUNDING/COMPETING INTEREST(s): No funding. N.M., J.F., D.N., and A.K. are employees and hold stock options of Future Fertility, the company that developed the AI model used. All other authors report no conflict of interest related with the content of this manuscript. TRIAL REGISTRATION NUMBER: n/a


  • Open Access

    Rescue in vitro maturation of germinal vesicle oocytes after ovarian stimulation: the importance of the culture media

    by Nuria Soler, Danilo Cimadomo, Laura Escrich, Noelia Grau, Arancha Galán, Pilar Alamá, María José de Los Santos, Laura Rienzi, María José Escribá

    STUDY QUESTION: What are the nuclear and initial developmental outcomes of rescue-IVM oocytes across multiple commercially available media? SUMMARY ANSWER: Of the 11 different media tested, Medium K provided the highest rescue rate in the shortest time and elicited the highest normal oocyte activation rate (NOAR). WHAT IS KNOWN ALREADY: Following ovarian stimulation, 10–15% of the oocytes are immature with about 10% states in prophase I, i.e. the germinal vesicle (GV) stage. A consensus is still needed whether to rescue these oocytes for clinical use or not, as reports of live births from rescued-metaphase-II (MII) oocytes continues to emerge. These oocytes may be valuable to poor prognosis patients when alternatives are not available and to oncofertility patients. Nonetheless, although rescue in vitro maturation (r-IVM) is experiencing a comeback, clear good practice recommendations regarding inherent protocols are lacking. Moreover, no commercially available culture media exist to support this potentially valuable rescue strategy. STUDY DESIGN, SIZE, DURATION: A prospective experimental study was conducted in a 1-year period at a private IVF center and entailing two consecutive phases. In study phase I, 1570 GV oocytes retrieved after ovarian stimulation from 490 young donors (maximum 4 per donor) were randomly cultured for 24 h in 11 commercially available culture media in a time lapse incubator. The two media eliciting the highest rescue rate in the shortest time were selected for study phase II. In this phase, 105 r-MII oocytes, obtained from 190 GVs rescued in the two chosen media, underwent artificial oocyte activation (AOA) and were further cultured in a time lapse incubator for 24 additional hours in Medium J until time of pronuclear fading (tPNf). PARTICIPANTS/MATERIALS, SETTING, METHODS: All donors (26.1 ± 3.8 years) underwent GnRH antagonist ovarian stimulation protocols with agonist trigger. The oocyte in vivo maturation rate was 80%. In the case of immature oocytes, two to four GV per woman were donated for research and cultured in an time lapse incubator. Time of GV breakdown (tGVBD) and time of the first polar body extrusion (t1PB) were annotated. AOA was conducted according to a previously published protocol. The primary outcome of study phase I was the rescue rate per cultured GV and the nuclear maturation dynamics in each medium studied. The primary outcome of study phase II was the NOAR of r-IVM oocytes in each selected medium. In this phase, time of pronuclear appearance and fading (tPNa and tPNf) and S-phase duration were also annotated. MAIN RESULTS AND THE ROLE OF CHANCE: The GVs cultured in 3 of the 11 tested media showed rescue rates ≥55%. However, the time to reach the r-MII in two of them, namely Medium G and Medium K, was significantly shorter (19.4 ± 0.2 h, 95%CI: 19.0–19.8 h). These two media were selected for study phase II. Following AOA, the NOAR obtained after rescue-IVM was significantly higher in the latter (n = 37/53, 70% vs. n = 21/52, 41%; P = 0.006, Power = 77%). No significant differences were observed in tPNa, tPNf or S-phase duration. LIMITATIONS, REASONS FOR CAUTION: The study was conducted in good-prognosis young oocyte donors and should be confirmed in poor-prognosis and/or advanced maternal age infertile women. Metaphase I (MI) immature oocytes were not included. AOA, which was used to assess initial oocyte competence (i.e. to resume meiosis and form a pronucleus), is useful for initial cytoplasmic competence but is an incomplete approach for the comprehensive assessment of cytoplasmic competence or further embryo development. In addition, tests such as microtubule and nuclear staining in r-MII to assess chromosome misalignment, organelle distribution and activity, non-invasive hyperspectral and AI oocyte analyses, more detailed morphodynamic assessments and, finally, analysis of meiotic segregation errors are mandatory to ensure the safety of r-MII oocytes prior to their potential clinical translation. Furthermore, due to the lack of knowledge regarding the qualitative and quantitative formulation of the commercially available culture media, to unravel the physiological mechanisms underlying the outcomes achieved is challenging. WIDER IMPLICATIONS OF THE FINDINGS: Among commercially available media not specifically designed for r-IVM, the media with glucose as main source of energy may show reduced rescue effectiveness. Conversely, the media with pyruvate as main source of energy, and combined with low lactate concentrations may elicit more favourable conditions to support both oocytes’ nuclear and initial cytoplasmic competence performance in GVs obtained after ovarian stimulation. This study provides first suggestions about which of the suboptimal systems would have the least detrimental effect on oocyte competence, thereby setting the stage for future appraisals for most effective rescue-IVM protocols. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the Instituto de Salud Carlos III, granted with the European Union (PI22/00924); the ‘Agencia Valenciana de la Innovación’ under the ‘Consolidación de la cadena de valor’ program of 2025 (INNCAD/2024/159) that is co-founded by the European Union through the ‘Programa Operativo FEDER’ de la Comunitat Valenciana 2021–2027, and by IVIRMA Valencia. The authors report no conflicts of interest related with the content of this manuscript. TRIAL REGISTRATION NUMBER: N/A.


  • Do we still need embryologists?

    by Giovanni Coticchio, Danilo Cimadomo, Laura Rienzi


  • Delays in the final stages of fertilization are strongly associated with trichotomous cytokinesis and cleavage arrest

    by Giovanni Coticchio, Lorena Marchio, Alessandro Bartolacci, Danilo Cimadomo, Carlotta Zacà, Cristina Lagalla, Nicoletta Tarozzi, Andrea Borini, Laura Rienzi

    Purpose Recent evidence showed that the phase between pronuclear fading and the first cleavage is a perilous bridge connecting the zygote and the embryo. Indeed, delay in the short interval between pronuclear breakdown (PNBD) and the first cytokinesis may result in chromosome segregation errors. We tested the hypothesis that delays in this final phase of fertilization are associated with a detrimental impact on embryo development. Methods This is a retrospective study of 1315 zygotes cultured using time lapse technologies generated in 205 first ICSI-cycles. Results We observed an association between increasing times of the pronuclear fading-first cleavage interval (t2-tPNf) and the rates of trichotomous/direct unequal cleavage at the first (DUC-1) and second (DUC-2) mitotic cycle. Moreover, we observed a reduced blastulation rate. No significant associations were observed between rates of direct unequal cleavage at the third mitotic cycle (DUC-3) and top-quality blastocysts, euploidy, and live births. To evaluate whether the interval t2–tPNf could have a predictive value for the onset of DUC-1 and DUC-2, ROC curve analyses were performed. The area under the curve values obtained for DUC-1 showed a significant prediction accuracy. The best cut-offs to identify zygotes with a high risk of DUC-1 and DUC-2 occurrence were t2–tPNf > 2.78 (hours) and t2–tPNf > 2.50 (hours), respectively. Conclusion Delay in the short interval between PNBD and the first cytokinesis result in trichotomous cleavage and early developmental arrest. However, if the embryos reach the blastocyst stage, rates of euploidy and live birth do not appear to be compromised.


  • Time will tell: time-lapse technology and artificial intelligence to set time cut-offs indicating embryo incompetence

    by Giovanni Coticchio, Alessandro Bartolacci, Valentino Cimadomo, Samuele Trio, Federica Innocenti, Andrea Borini, Alberto Vaiarelli, Laura Rienzi, Aisling Ahlström, Danilo Cimadomo

    STUDY QUESTION: Can more reliable time cut-offs of embryo developmental incompetence be generated by combining time-lapse technology (TLT), artificial intelligence, and preimplantation genetics screening for aneuploidy (PGT-A)? SUMMARY ANSWER: Embryo developmental incompetence can be better predicted by time cut-offs at multiple developmental stages and for different ranges of maternal age. WHAT IS KNOWN ALREADY: TLT is instrumental for the continual and undisturbed observation of embryo development. It has produced morphokinetic algorithms aimed at selecting embryos able to generate a viable pregnancy, however, such efforts have had limited success. Regardless, the potential of this technology for improving multiple aspects of the IVF process remains considerable. Specifically, TLT could be harnessed to discriminate developmentally incompetent embryos: i.e. those unable to develop to the blastocyst stage or affected by full-chromosome meiotic aneuploidies. If proven valuable, this application would prevent the non-productive use of such embryos, thereby improving laboratory and clinical efficiency and reducing patient stress and costs due to unnecessary embryo transfer and cryopreservation. STUDY DESIGN, SIZE, DURATION: The training dataset involved embryos of PGT-A cycles cultured in Embryoscope with a single media (836 euploid and 1179 aneuploid blastocysts and 1874 arrested embryos; 2013–2020). Selection criteria were ejaculated sperm, own (not donated) fresh oocytes, trophectoderm biopsy and comprehensive-chromosome-testing to diagnose uniform aneuploidies. Out-of-sample (30% of training), internal (299 euploid and 490 aneuploid blastocysts and 680 arrested embryos; 2021–2022) and external (97 euploid, 110 aneuploid and 603 untested blastocysts and 514 arrested embryos, 2018 to early 2022) validations were conducted. PARTICIPANTS/MATERIALS, SETTING, METHODS: A training dataset (70%) was used to define thresholds. Several models were generated by fitting outcomes to each timing (tPNa-t8) and maternal age. ROC curves pinpointed in-sample classification values associated with 95%, 99% and 99.99% true-positive rate for predicting incompetence. These values were integrated with upper limits of maternal age ranges (42 years) in logit functions to identify time cut-offs, whose accuracy was tested on the validation datasets through confusion matrices. MAIN RESULTS AND THE ROLE OF CHANCE: For developmental (in)competence, the best performing (i) tPNa cut-offs were 27.8 hpi (error-rate: 0/743), 32.6 hpi (error rate: 0/934), 26.8 hpi (error rate: 0/1178), 22.9 hpi (error-rate: 1/654, 0.1%) and 17.2 hpi (error rate: 4/423, 0.9%) in the 42 years groups, respectively; (ii) tPNf cut-offs were 36.7 hpi (error rate: 0/738), 47.9 hpi (error rate: 0/921), 45.6 hpi (error rate: 1/1156, 0.1%), 44.1 hpi (error rate: 0/647) and 41.8 hpi (error rate: 0/417); (iii) t2 cut-offs were 50.9 hpi (error rate: 0/724), 49 hpi (error rate: 0/915), 47.1 hpi (error rate: 0/1146), 45.8 hpi (error rate: 0/636) and 43.9 hpi (error rate: 0/416); (iv) t4 cut-offs were 66.9 hpi (error rate: 0/683), 80.7 hpi (error rate: 0/836), 77.1 hpi (error rate: 0/1063), 74.7 hpi (error rate: 0/590) and 71.2 hpi (error rate: 0/389); and (v) t8 cut-offs were 118.1 hpi (error rate: 0/619), 110.6 hpi (error rate: 0/772), 140 hpi (error rate: 0/969), 135 hpi (error rate: 0/533) and 127.5 hpi (error rate: 0/355). tPNf and t2 showed a significant association with chromosomal (in)competence, also when adjusted for maternal age. Nevertheless, the relevant cut-offs were found to perform less well and were redundant compared with the blastocyst development cut-offs. LIMITATIONS, REASONS FOR CAUTION: Study limits are its retrospective design and the datasets being unbalanced towards advanced maternal age cases. The potential effects of abnormal cleavage patterns were not assessed. Larger sample sizes and external validations in other clinical settings are warranted. WIDER IMPLICATIONS OF THE FINDINGS: If confirmed by independent studies, this approach could significantly improve the efficiency of ART, by reducing the workload and patient impacts (extended culture and cleavage stage cryopreservation or transfer) associated with embryos that ultimately are developmentally incompetent and should not be considered for treatment. Pending validation, these data might be applied also in static embryo observation settings. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the participating institutions. The authors have no conflicts of interest to declare TRIAL REGISTRATION NUMBER: N/A.


  • Open Access

    Embryo multinucleation: detection, possible origins, and implications for treatment

    by Giovanni Coticchio, Cristina Lagalla, Marilena Taggi, Danilo Cimadomo, Laura Rienzi

    Cell cycle regulation is crucial to assure expansion of a cell population, while preserving genome integrity. This notion is especially relevant to fertilization and early embryo development, a time when the cell cycle transforms from meiotic into mitotic cycles. Zygote-to-embryo transition is acutely error-prone, causing major developmental perturbations, including cleavage delays, tri- and multi-chotomous cleavages, and cell fragmentation. Another such alteration is bi- and multinucleation, consisting of the simultaneous formation of two or more nuclei at interphase. Indeed, multinucleation affects a large proportion of early human embryos, typically at the two-cell stage. Mechanistically, several factors, including spindle dysfunction, failed cleavage, and cell fusion, may generate this cell anomaly. In assisted reproduction treatment, multinucleation is associated with reduced developmental rates and lower implantation rates in Days 2–3 embryo transfers. However, many multinucleated embryos can develop to the blastocyst stage. In blastocyst transfers, the current evidence does not suggest a major impact of a previous history of multinucleation on the odds of euploidy or successful treatment outcomes. Human embryo multinucleation remains a not-fully-understood but developmentally relevant and intriguing phenomenon which requires further research of its generative mechanisms and clinical implications.